Hello,

Sign up to join our community!

Welcome Back,

Please sign in to your account!

Forgot Password,

Lost your password? Please enter your email address. You will receive a link and will create a new password via email.

Sorry, you do not have permission to ask a question, You must login to ask a question.

Please briefly explain why you feel this question should be reported.

Please briefly explain why you feel this answer should be reported.

Please briefly explain why you feel this user should be reported.

Home Latest Topics

  • 81
  • 81
Bloomberg Television

Lilly’s Zepbound beats Novo’s Wegovy in head-to-head trial #shorts #zepbound #wegovy 😛

video
play-sharp-fill
00:44

Eli Lily’s weight loss drug Zep bound outperformed Novo not discs in the first head-to-head trial sponsored by Lily patients were found to lose an average of 20% of their body weight compared to 14% with wovi the first ever head-to-head study 50 pounds weight loss on average for Zep bound versus 33 for wovi I think that’s important information it’s actually probably the most common question we get from patients and and doctors is i’ I’ve heard there’s these two different weight loss drugs uh how do they compare and so this is great data and I think as you’re pointing out uh the next steps are are to to talk to Regulators understand how we can use this and and communicate this to to doctors in in the best way

Related Topics

You must login to add an answer.